Top Markets
Coin of the day
Gwo Xi Stem Cell Applied Technology Co. , Ltd Gwo Xi Stem Cell Applied Technology Co. , Ltd

Gwo Xi Stem Cell Applied Technology Co. , Ltd

6704
Rangering i aksjer #24642
Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem... Gwo Xi Stem Cell Applied Technology Co., Ltd. is dedicated to advancing stem cell-based therapies, addressing critical unmet medical needs in patient care. Its product pipeline currently features two pioneering autologous adipose-derived stem cell treatments: GXHPC1, which is in Phase II clinical trials for liver cirrhosis, and GXNPC1, also undergoing Phase II testing, designed for the management of chronic stroke. Further expanding its therapeutic portfolio, the company is advancing GXCPC1, an allogeneic adipose-derived stem cell therapy currently in combined Phase I/II clinical trials for osteoarthritis, alongside GXIPC1, another allogeneic fat-derived stem cell treatment in early-stage Phase I trials for diabetes. Established in 2011, the company maintains its headquarters in Zhubei, Taiwan.
Aksjekurs
$0.60736143
Markedsverdi
$58.28M
Endring (1 dag)
-1.04%
Endring (1 år)
-21.09%
Land
TW
Handel Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)

Kategori

Aksjeprishistorikk for Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704)
Høyeste sluttskurs: $0.61 den 2026-08-01

Laveste sluttskurs: $1.47 den 2023-04-01
Aksjeprishistorikk for Gwo Xi Stem Cell Applied Technology Co. , Ltd fra 2023 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -11.38%
2025 1.08%
2024 -27.87%
2023 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$550.92 38.61%
US
$1.06K 59.05%
NL
$147.61 462.97%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH